Stevanato Group S.p.A.: Stevanato Group Reports Third Quarter 2022 Financial Results
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced